C erebral cavernous malformations (CCMs) are low-flow vascular malformations in the brain affecting ≤1 in 250 individuals. CCM lesions consist of a mulberry-like cluster of enlarged and irregular blood vessels surrounded by a thick, multilayered basal membrane. 1, 2 The endothelial channels have poorly developed tight and adherens junctions, and are rarely covered by pericytes, astrocytes, or vascular smooth muscle cells (VSMCs). [3] [4] [5] Growth and bleeding of CCM lesions cause neurological defects, such as pharmacorefractory epilepsy, migraine-like headaches, focal neurological deficits, and hemorrhages. 1, 2 CCM is caused by loss-of-function mutations in the CCM1 (KRIT1), CCM2 (OSM), and CCM3 (PDCD10) genes. The detailed pathobiology is still not understood. However, many functions of these genes in cultured endothelial cells were recently described. Increased stress fiber formation, cell shape changes, and weakening of adherens junctions were observed after silencing CCM1-3 genes in endothelial cells. 1 A recent landmark study suggested that endothelial cells adopt a more mesenchymal cell-like phenotype (endothelial-to-mesenchymal transition) on loss of the Ccm1 gene. This behavior is, in part, because of decreased Notch signaling. 6 Second, CCM proteins are crucial for endothelial cell interactions with the extracellular matrix. 7 Finally, CCM1 inhibits angiogenesis via induction of Notch signaling. 8, 9 Notch signaling is essential to restrain sprouting angiogenesis and loss of Dll4 or Notch1 in mice leads to a chaotic, tip cell-rich, and excessively branched vessel network that is poorly functional. 10 Notch signaling requires protein interactions between a Notch ligand (Dll1, Dll3, Dll4, Jag1, and Jag2)
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May 2015 and a receptor (Notch1-4) located on adjacent cells. This leads to processing by a disintegrin and metalloproteinase domain protease and γ-secretase to release the Notch intracellular domain. Notch intracellular domain enters the nucleus and activates the transcription factor recombination signal-binding protein-Jκ to induce gene expression of HES and HEY transcriptional repressors, 10 and several cell-type-specific target genes, such as ephrin-B2 in endothelial cells and plateletderived growth factor (PDGF) receptor β in VSMC. 11, 12 Notch signaling also occurs between endothelial and mural cells. Endothelial-specific ablation of recombination signalbinding protein-Jκ reduces pericyte adhesion leading to hemorrhage. 13 The endothelial cell-specific loss of the Notch ligand Jagged-1 dramatically impairs VSMC differentiation. 14 Finally, Notch3 expression is transmitted through the vessel wall in an autoregulatory loop that requires the contact of VSMC with endothelial cells. 15 In contrast to VSMC, the functions of Notch signaling in pericytes are poorly understood. One would assume that Notch receptors on pericytes can be stimulated by ligands located on endothelial cells because both the cell types form peg-and-socket contacts containing adherens and gap junctions. Pericytes are important to inhibit angiogenesis, to stabilize the vessel wall, to limit vessel permeability, 16 to strengthen the blood-brain barrier, 17 and to control cerebral blood flow. 18 This study was aimed to determine whether endothelial DLL4 ligands, whose expression is controlled by CCM1, can stimulate Notch3 receptors on pericytes and to evaluate functions of Notch3 signaling in pericytes.
Materials and Methods
Cell Culture
Human umbilical vein endothelial cells (HUVECs) were cultured in Endopan-3 medium with supplements (PAN Biotech) for ≤4 passages. Human brain microvascular endothelial cells (Cell Systems, ACBRI 376) were cultured in Complete Classic Medium (Cell Systems, 4Z0-500). Human brain pericytes (HBPCs) were purchased from ScienCell, California and grown in pericyte medium with 2% fetal bovine serum, and supplements (ScienCell). HBPCs were characterized by immunostaining against smooth muscle actin. The manipulation with siRNA or shRNA, Western blotting, and quantitative polymerase chain reaction are described in the online-only Data Supplement.
Mouse Cavernoma Tissue and Ccm1-Deficient Mice
The endothelial cell-specific Ccm1-deficient mice have been described before. 19 Mice were injected with 20 μg/g tamoxifen at postnatal day 1 and euthanized at day 8 to obtain cavernoma tissue from the cerebellum.
In Vivo Spheroid-Based Angiogenesis Assay
This assay was performed as described before. 8, 20, 21 In short, HUVEC were transduced with lentiviral particles expressing shRNA against either CCM1 or CCM1 cDNA. After antibiotic selection spheroids containing 150 cells were generated. Thousand spheroids were embedded in a 1:1:1 mixture of Endopan-3/methocel/fibrinogen containing 1 μg/mL vascular endothelial growth factor-A 165 and fibroblast growth factor 2. Immediately before injection, this mixture was diluted 1:1 with growth factor-reduced Matrigel (BD Biosciences) and 1 U/μL thrombin (Calbiochem). This mixture was injected subcutaneously into the flank of 6-to 8-week-old CB17 SCID mice (Charles River). Each mouse received 2 injections with CCM1-mutant and control cells, respectively. Plugs were removed 28 days later, fixed with 4% paraformaldehyde and embedded in paraffin. All animal procedures were performed in accordance with the local committee for animal experiments. Immunohistochemistry methods are further detailed in the online-only Data Supplement.
rhDLL4 Stimulation
Recombinant human DLL4 protein (2.5 μg; R&D) or 2.5 μg IgG as control (Rockland) were diluted in 1 mL 0.1% gelatin in phosphate buffered saline. Six-well dishes were coated with 1 mL of this mixture for 12 hours at 4°C. The solution was removed and 5×10 5 HBPC were seeded. RNA and proteins were isolated 24 hours later. For tube formation 2.5×10 4 HBPC and HUVEC were seeded together on top of Matrigel in a 48-well plate. The ratio HBPC/HUVEC was 1:1 (Notch3 overexpressing HBPC) or 1:4 (Notch3-silenced HBPC). The assay was stopped 18 hours later. Bright field microscopy was performed with Zeiss Cell Observer and cumulative length of the capillary network measured with cell^P software. By means of tile scans, the whole well was analyzed and considered as 1 sample.
Adhesion
The spheroid-based angiogenesis assay was performed as described. 11 The cumulative sprout length of 30 spheroids was measured (Olympus IX 50, cell^P software).
Statistical Analysis
Results are expressed as mean±SD. Comparisons between 2 groups were analyzed with SigmaPlot 12.0 software by a 2-sided t test. P≤0.05 were considered as statistically significant.
Results
Endothelial CCM1 Expression is Prerequisite for Pericyte Coverage
Endothelial channels are poorly covered by mural cells within CCMs. [3] [4] [5] Our groups have recently developed mouse models for this neurovascular disease. 6, 8, 19 Endothelial cellspecific ablation of Ccm1 in newborn mice by Cre-ERT2/ loxP technology leads to the formation of enlarged blood vessels and vascular conglomerates in the brain and the retina. 19 Immunohistological analysis revealed that CCM lesions in the cerebellum of 8-day-old iCcm1 ΔEC/EC -deficient mice contained only few periendothelial cells. The nonaffected blood vessels adjacent to CCM lesions had a normal appearance and were covered by pericytes similar as in control animals ( Figure 1A ).
Second, we analyzed mural cell coverage of vessels derived from CCM1-silenced human endothelial cells in a xenograft mouse model. In this approach, the HUVECs were stably transduced with shRNA against CCM1 and grafted subcutaneously in immunodeficient mice. HUVEC form a vascular network that anastomoses with the invading murine vessels. 20 , 21 We had shown before that CCM1 gene depletion leads to the formation of a hyperdense vascular network with and increased vessel lumen size. 8 The abnormal vessels were significantly less covered by desmin-positive periendothelial cells compared with control (16% versus 50%; P<0.001; Figure 1B and 1C). As such, both the animal models recapitulate hallmarks of human CCM lesions.
Previously, we found that forced CCM1 protein expression inhibits sprouting angiogenesis because of elevated Dll4-Notch signaling. 8 Here, we show that HUVEC overexpressing CCM1 formed only few vessels after xenotransplantation into mice ( Figure IA and IB in the online-only Data Supplement).
Microvessel density was reduced by ≈80% compared with grafted endothelial cells expressing green fluorescent protein. These vessels were, however, covered by desmin-positive mural cells in the same extent as in the control animals ( Figure  IC in the online-only Data Supplement). Taken together, a certain threshold dose of CCM gene expression in endothelial cells seems to be necessary to recruit and stably incorporate mural cells into the blood vessel wall.
DLL4 Induces Notch3 Signaling in Pericytes
Depletion of CCM1 or CCM3 in endothelial cells is followed by impaired DLL4-Notch signaling and excessive sprouting. 6, 8, 9, 22 We hypothesized that CCM1-depletion could also affect Notch signaling between endothelial cells and pericytes. It has not yet been formally demonstrated that DLL4 ligands can stimulate Notch3 receptors on pericytes. An efficient and rather clean method to stimulate Notch receptors is to cultivate cells on immobilized, recombinant ligand proteins. When human brain pericytes (HBPC) were cultured on immobilized DLL4 protein a robust induction of Notch3 protein expression was observed. Importantly, the rate of cleaved, and thus active, Notch3 intracellular domain was significantly increased. The mural cell-specific Notch target gene PDGF receptor-β (PDGFRB) was also induced (Figure 2A ). Consequently, increased mRNA expression of the classical Notch target genes HEY2, HEYL, and PDGFRB was observed on stimulation of pericytes with DLL4 ( Figure IIA in the online-only Data Supplement).
Next, we silenced CCM1 expression in HUVEC (knockdown rate >80%) and cocultured these with HBPC. Silencing of CCM1 significantly reduced endothelial DLL4 expression to 60% (P<0.01) but did not affect expression levels of the Notch ligands DLL1 and JAG1 ( Figure 2B ; Figure IIB in the onlineonly Data Supplement). Endothelial CCM1 silencing decreased expression of NOTCH3 protein in cocultured HBPC ( Figure 2B ). Consequently, less NOTCH3 expression was associated with decreased amounts of the active Notch3 intracellular domain (NOTCH3-ICD) and mRNA of its target genes PDGFRB and HEYL ( Figure IIC in the online-only Data Supplement). This is cell-type-specific because HUVEC do not express NOTCH3 ( Figure IID in the online-only Data Supplement). The same was seen when CCM1 was silenced in human brain microvascular endothelial cells ( Figure 2B ). In addition, NOTCH3 and PDGFRB levels in pericytes were restored or even increased by DLL4 overexpression in HUVEC after CCM1 silencing ( Figure 2C ). Taken together, DLL4 is not only important for NOTCH1 receptor stimulation within the endothelium but can also activate NOTCH3 receptors on pericytes.
Notch3 Signaling in Pericytes Regulates Different Aspects of Pericyte-Endothelial Cell Interactions
To explore the functions of Notch3 signaling in pericytes (HBPC), NOTCH3 gene expression was silenced by 2 independent lentiviral shRNAs. Both the shRNAs significantly reduced NOTCH3 mRNA levels by >90% and the resulting protein depletion was confirmed by Western blotting. Notch3 gain-of-function experiments were conducted by overexpressing the NOTCH3-ICD with lentiviral vectors. ) at postnatal day 1. Brains were analyzed for cavernoma formation 7 days later. Representative sections show cerebral cavernous malformation (CCM) lesions in the cerebellum. Endothelial cells were stained with fluorescein-5-isothiocyanate (FITC)-lectin (false color red) and pericytes with desmin, platelet-derived growth factor receptor-β (PDGFRB) or smooth muscle actin (SMA) antibodies (green). Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; blue). Affected vessels are large, of irregular shape, and almost devoid of pericytes. Blood vessels in healthy brain tissues have normal vessel morphology. n=3 mice. B and C, Human umbilical vein endothelial cells (HUVECs) lentivirally silenced for CCM1 gene expression were transplanted in a Matrigel/fibrin plug into immunodeficient mice. HUVEC lentivirally transduced with a nonsilencing shRNA served as control. Representative paraffin sections of plugs stained with human-specific anti-CD34 (HUVEC, red) and antidesmin (mural cells, green). Nuclei were stained with DAPI (blue). Pericyte coverage was defined as a CD34 positive vessel covered by at least 50% with directly colocalized desminpositive periendothelial cells. Mural cell coverage was severely impaired in blood vessel networks derived from HUVEC silenced for CCM1 expression. n=7 plugs for the CCM1-depletion group and n=10 plugs for the control group. Results are shown as mean±SD, ***P<0.001. Scale bars, 50 μm. 
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First, the ability of HBPC to invade into a collagen matrix was assessed. NOTCH3 silencing led to a >2-fold increase in pericyte outgrowth ( Figure 3A) , whereas overexpression of NOTCH3-ICD significantly reduced the invasion capacity of pericytes ( Figure 3B ). This was further analyzed by pericyteendothelial cell coculture assays. The adhesion of pericytes to a dense HUVEC monolayer was strongly impaired after NOTCH3 silencing in pericytes (51% reduction). Consistently, the overexpression of NOTCH3-ICD significantly increased the rate of pericyte adhesion by ≈100% (Figure 3C and 3D) .
The adhesion of pericytes to endothelial cells helps to maintain vessels in a quiescent, nonangiogenic state. 17, 23 A coculture Matrigel assay with HUVEC and HBPC was used to study a potential role of Notch3 in pericytes for the control of endothelial tube formation. When HBPC were added to HUVEC in a 1:1 ratio, this almost prevented tube formation. However, silencing NOTCH3 in pericytes allowed endothelial tube formation ( Figure 4A and 4B) . Elevated Notch3 signaling in HBPC led to a remarkable reduction of tube formation, even when HBPC were cocultured with HUVEC only in a 1:4 ratio ( Figure 4C and 4D) . In summary, the experiments imply that the inhibition of Notch signaling in pericytes makes these cells more motile, less adhesive, and impairs their capability to inhibit angiogenesis.
Notch3-Regulated Genes are Key Players in Pericyte Physiology
To gain first insights into the transcriptome of Notch3 signaling in human brain pericytes, we performed quantitative reverse transcription polymerase chain reaction with selected genes that are known to guide critical pericyte-endothelial cell interactions. NOTCH3 silencing in HBPC significantly reduced both mRNA and protein level of PDGFRB2 and the adhesion molecule N-Cadherin, as well as the expression of the heparin-binding epidermal growth factor (HBEGF) and transforming growth factor β-1 (TGFB1; Figure 5A and 5C). Consistent to this NOTCH3-ICD, overexpression significantly increased expression of PDGFRB2, N-Cadherin, HBEGF, TGFB1, the transmembrane chondroitin sulfate proteoglycan NG2, and sphingosine-1-phosphate S1P (Figure 5B and 5C). These changes seem to be specific because expression of several additional genes were not changed ( Figure III in the online-only Data Supplement). Taken together, Notch3 signaling regulates complex genetic programs that are essential for 
Discussion
Many functions of the CCM proteins were deciphered in the past years. It is obvious that these proteins execute critical roles to regulate cytoskeletal remodeling, adherens junctions, cell polarity, lumen formation, endothelial-to-mesenchymal transition, and angiogenesis.
1,2,6,9,19,22,24-26 Nevertheless, it is not yet clear which of these functions is predominantly responsible for the initiation of lesion formation. In this regard, it is noteworthy that endothelial cells silenced for CCM gene expression are more susceptible toward angiogenic stimuli, 8, 9, 22 implicating that minor injuries or hypoxic episodes may trigger CCM development.
Impaired Notch signaling was observed in CCM1-or CCM3-silenced endothelial cells, 8, 9 and endothelial cell-specific Ccm1 
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knockout mice. 6 This may significantly contribute to uncontrolled angiogenesis during lesion formation because loss of Notch signaling sensitizes endothelial cells for the growth factor vascular endothelial growth factor. 10 The question why CCM lesions are almost devoid of mural cells (pericytes and VSMCs) has, however, not yet been systematically addressed. The presence of pericytes at the blood-brain barrier is essential for limiting transendothelial transport, 27 and the control of blood perfusion. 28 The blood-brain barrier is impaired in cerebral cavernomas. 3 Our approaches to silence CCM gene expression exclusively in endothelial cells resulted in formation of enlarged and irregular branched endothelial channels. These malformations were additionally only poorly covered by pericytes. We still detected some remaining pericytes in cavernoma-like lesions of iCcm1 ΔEC/EC mice. Because the progression of the number and size of these lesions occurs rapidly, we intended to analyze an early state after gene ablation. Even 7 days after tamoxifen injection the vascular channels were strongly enlarged, irregular, and had either lost or failed to recruit pericytes. Moreover, the data suggest that signaling from the endothelium toward pericytes is severely affected on impaired CCM gene expression in endothelial cells.
This study showed that DLL4 is important for the cross-talk of endothelial cells with pericytes in CCM. Other groups provided evidence of Dll4 enhancing pericyte coverage of tumor vessels, 29, 30 and defective vessel maturation and perfusion is a result of Dll4 ablation. 31 Defective recruitment of pericytes, hyperproliverative angiogenesis, enhanced permeability, insufficient maturation and perfusion are all well-known aspects in CCM pathology and underline the relevance of Dll4-Notch3 signaling in this neurological entity.
To date, it is known that the Notch ligand Jagged-1 on endothelial cells is crucial to stimulate Notch3 signaling in the adjacent layer of VSMCs. [13] [14] [15] 32 However, Jagged-1 expression is not altered in CCM1 or CCM3-silenced endothelial cells, whereas only DLL4 protein levels are decreased. 8, 9 DLL4 is expressed exclusively on endothelial cells in the vasculature. It has not yet been formally tested whether DLL4 can stimulate Notch3 receptors in pericytes, which are abundantly expressed on these cells. 23 Our data revealed that recombinant DLL4 protein can efficiently stimulate Notch3 signaling in pericytes. This may have several implications. We found that Notch3 signaling in human brain pericytes enhanced the adhesion to endothelial cells and limited the migratory and invasive behavior of mural cells. DLL4-Notch3 signaling would help to maintain stable endothelial cell-pericyte interactions within the vessel wall and, therefore, may play a substantial role in blood-brain barrier homeostasis. The role of Notch3 in pericytes for maintaining blood-brain barrier function as well as positively controlling pericyte coverage was recently shown in zebrafish. 33 These findings are in accordance with our work pointing out Notch3 as functionally relevant for the pericyte-endothelial cell interplay.
Our experiments showed that Notch3 controlled the prototypic signaling mode between the endothelium and mural cells, the PDGFB/PDGFRB signaling system. This is similar to the situation in VSMCs. 12 PDGFB is essential for the recruitment of pericytes in the central nervous system and the establishment of a tight bloodbrain barrier. 17, 34 Histopathologic findings provided evidence of elevated levels of PDGF in CCM lesions. 35, 36 Considering that the PDGFβ receptor is downregulated on decreased Notch3 activity in pericytes, this can be seen as a compensatory mechanism.
Finally, we found that the antiangiogenic capability of pericytes 23 is, in part, dependent on Notch3 signaling. Therefore, we hypothesize that CCM gene deletion makes endothelial cells susceptible for growth stimuli and that impaired Notch activity aggravates this. It allows excessive vessel branching 10, 37, 38 and facilitates endothelial-to-mesenchymal transition. 6 The resulting endothelial channels are impaired to recruit pericytes, a situation that additionally weakens the blood-brain barrier, vessel integrity, and facilitates further vessel growth. 
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